Steven Dabbs

A Novel, Potent, and Selective 5-HT₇Antagonist:  (<i>R</i>)-3-(2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)

Peter J. Lovell, Steven M. Bromidge, Steven Dabbs et al. · Journal of Medicinal Chemistry · 2000 · 248 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Science +14

(<i>R</i>)-3,<i>N</i>-Dimethyl-<i>N</i>-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzenesulfonamide:  The First Selective 5-HT₇Receptor Antagonist

Ian T. Forbes, Steven Dabbs, D. Malcolm Duckworth et al. · Journal of Medicinal Chemistry · 1998 · 102 citations · Full text

Drug Target, Altmetric Attention Score, Pharmacotherapy +16

Biarylcarbamoylindolines Are Novel and Selective 5-HT_2C Receptor Inverse Agonists:  Identification of 5-Methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a Potential Antidepressant/Anxiolytic Agent

Steven M. Bromidge, Steven Dabbs, David T. Davies et al. · Journal of Medicinal Chemistry · 2000 · 79 citations · Full text

Potential Antidepressant/anxiolytic Agent, Psychotropic Medication, Inverse Agonists +18

Novel and Selective 5-HT_2C/2B Receptor Antagonists as Potential Anxiolytic Agents:  Synthesis, Quantitative Structure−Activity Relationships, and Molecular Modeling of Substituted 1-(3-Pyridylcarbamoyl)indolines

Steven M. Bromidge, Steven Dabbs, David T. Davies et al. · Journal of Medicinal Chemistry · 1998 · 64 citations · Full text

Biological Activity, Molecular Pharmacology, Medicinal Chemistry +15

Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerases

Timothy J. Miles, Alan J. Hennessy, B.D. Bax et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 63 citations · Full text

Inhibitory Activity, Medicinal Chemistry, Medicine +13